STEVEN BARTON: Open Payments
NPI 1295849644 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,081 in 85 payments from 17 companies in 2025. Trend: 2023 $4,146 · 2024 $1,565 · 2025 $3,081
Food & beverage: $2,146Travel & lodging: $935
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company | 23 | $1,510 |
| Gilead Sciences, Inc. | 20 | $608 |
| Ferring Pharmaceuticals Inc. | 4 | $100 |
| Merck Sharp & Dohme LLC | 4 | $99 |
| PFIZER INC. | 3 | $86 |
| Astellas Pharma US Inc | 4 | $85 |
| Melinta Therapeutics, LLC | 3 | $77 |
| Aimmune Therapeutics, Inc. | 3 | $74 |
| Napo Pharmaceuticals Inc | 3 | $67 |
| Insmed, Inc. | 2 | $61 |
Products named: DOVATO, APRETUDE, REBYOTA, CABENUVA, OCTAGAM IMMUNE GLOBULIN (HUMAN), Cresemba, Rezzayo, VOWST.
Industry payments across GA — which companies pay providers there.
